What is really in the Onc Pipeline?

Discussion in 'Cephalon' started by Anonymous, Oct 10, 2013 at 12:24 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Treanda-done in a year
    Synribo -bust
    Growth factors-exclusive for awhile but then hoards of competition
    Trisenox -small
    Custirsen-keeping fingers crossed....

    No company or compound purchases---120 reps....stability can be gone in a flash
     

  2. Anonymous

    Anonymous Guest

    We are a sinking ship.
     
  3. Anonymous

    Anonymous Guest

    BB
     
  4. Anonymous

    Anonymous Guest

    Let's not forget the duo - BC and MS!
     
  5. Anonymous

    Anonymous Guest

    BB
     
  6. Anonymous

    Anonymous Guest

    What stability?
     
  7. Anonymous

    Anonymous Guest

    BB
     
  8. Anonymous

    Anonymous Guest

    Why did the booth as ASH have NO product pipeline like every other robust hem/onc company?
     
  9. Anonymous

    Anonymous Guest

    Why do we have a sales director that never sold nor directed?
     
  10. Anonymous

    Anonymous Guest

    BB
     
  11. Anonymous

    Anonymous Guest

    Odd teleconference on Friday. Losing at least 2 high performing sales people in recent months, MS decided to review why our compensation package is among the leaders in the industry. What? Wait, say that again Matt?? Add self delusion to his list of dysfunctional attributes. Bill and Matt are in way over their head, constantly turning their head on reality and selling each other on why they can effectively lead a dying business unit. I am out of here at the beginning of next year and I hope everyone can recognize the music is coming from the band on the deck of the Teva Titanic.
     
  12. Anonymous

    Anonymous Guest

    BB
     
  13. Anonymous

    Anonymous Guest

    At least BB is still very skilled at kissing MS & BC's rear ends. Maybe his patented delivery system should be worked into an NTE?